Domain

Time

Group

Unadjusted p-value

Adjusted p-value

Mate Endurance (n = 32)

Placebo (n = 30)

Sexual Satisfaction

Start of intervention

26.6 ± 9.1

25.0 (12.5 - 50.0)

25.2 ± 4.8

25.0 (18.7 - 37.5)

0.547a

<0.001b

12 weeks past intervention

44.7 ± 14.3

50.0 (25.0 - 68.7)

30.0 ± 9.9

25.0 (12.5 - 50.0)

<0.001a

Mean differential

18.2 ± 16.3

15.6 (0.0 - 43.7)

4.8 ± 11.1

0.0 (−12.5 - 31.2)

<0.001a

p-value

<0.001c

0.033c

Start of intervention

10.3 ± 9.1

6.2 (0.0 - 25.0)

11.7 ± 6.7

12.5 (0.0 - 25.0)

0.397a

0.524b

Control

12 weeks past intervention

17.2 ± 8.2

18.7 (0.0 - 25.0)

16.7 ± 8.3

18.7 (0.0 - 31.2)

0.705a

Mean differential

6.8 ± 8.6

3.1 (0.0 - 25.0)

5.0 ± 7.7

0.0 (−6.2 - 18.7)

0.401a

p-value

<0.001c

0.003c

Start of intervention

9.8 ± 9.9

12.5 (0.0 - 25.0)

11.7 ± 9.2

12.5 (0.0 - 25.0)

0.403a

<0.001b

Distress

12 weeks past intervention

31.6 ± 17.4

25.0 (0.0 - 50.0)

18.3 ± 10.7

25.0 (0.0 - 25.0)

0.005a

Mean differential

21.9 ± 17.7

18.7 (0.0 - 50.0)

6.7 ± 12.2

0.0 (−12.5 - 25.0)

0.001a

p-value

<0.001c

0.007c